Literature DB >> 1923357

Posterior polymorphous dystrophy and Alport syndrome.

C Teekhasaenee1, S Nimmanit, S Wutthiphan, K Vareesangthip, T Laohapand, P Malasitr, R Ritch.   

Abstract

Seventeen Thai patients from nine families with Alport syndrome underwent complete ocular examination and specular microscopy. Fourteen (82.3%) patients had ocular changes. Eleven (64.7%) had endothelial vesicles compatible with posterior polymorphous dystrophy. Four of these also had subepithelial opacities, a previously undescribed phenomenon. Other ocular changes included lenticonus and macular and midperipheral retinal flecks. A second group of 18 consecutive patients from 14 families with posterior polymorphous dystrophy detected during routine ocular examination underwent renal evaluation. Five had hematuria, four of whom had sensorineural hearing loss. Two of the four patients also had characteristic renal biopsy findings. Another had sensorineural hearing loss without hematuria, and renal biopsy showed a thin glomerular basement membrane. Posterior polymorphous dystrophy is a common but frequently overlooked finding in Alport syndrome. The frequent association of these two hereditary conditions suggests a common defect in basement membrane formation. Patients with posterior polymorphous dystrophy should be examined for renal abnormalities and hearing loss.

Entities:  

Mesh:

Year:  1991        PMID: 1923357     DOI: 10.1016/s0161-6420(91)32152-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Authors:  Anthony J Aldave; Lydia B Ann; Ricardo F Frausto; Catherine K Nguyen; Fei Yu; Irving M Raber
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

3.  Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.

Authors:  Michelle S Jang; Ashley N Roldan; Ricardo F Frausto; Anthony J Aldave
Journal:  Vision Res       Date:  2014-04-26       Impact factor: 1.886

4.  Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

Authors:  Wen Ding; Keyvan Yousefi; Stefania Goncalves; Bradley J Goldstein; Alfonso L Sabater; Amy Kloosterboer; Portia Ritter; Guerline Lambert; Armando J Mendez; Lina A Shehadeh
Journal:  JCI Insight       Date:  2018-03-22

Review 5.  Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Authors:  Y Q Soh; Viridiana Kocaba; Mauricio Pinto; Jodhbir S Mehta
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

6.  Progressive posterior lenticonus in a patient with alport syndrome.

Authors:  Ammar M Al-Mahmood; Samar A Al-Swailem; Abdulrahman Al-Khalaf; Ghada Y Al-Binali
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

7.  Clinical characterization of posterior polymorphous corneal dystrophy in patients of Indian ethnicity.

Authors:  Sunita Chaurasia; Rashmi Mittal; G Bichappa; Muralidhar Ramappa; Somasheila I Murthy
Journal:  Int Ophthalmol       Date:  2016-09-22       Impact factor: 2.031

Review 8.  Opinion: Ocular features aid the diagnosis of Alport syndrome.

Authors:  Judy Savige; Deb Colville
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

Review 9.  DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

Authors:  Judy Savige; Elisabet Ars; Richard G H Cotton; David Crockett; Hayat Dagher; Constantinos Deltas; Jie Ding; Frances Flinter; Genevieve Pont-Kingdon; Nizar Smaoui; Roser Torra; Helen Storey
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

10.  Temporal macular thinning associated with X-linked Alport syndrome.

Authors:  Faisal Ahmed; Kandon K Kamae; Denise J Jones; Margaret M Deangelis; Gregory S Hageman; Martin C Gregory; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.